MALLADI DRUGS PHARMACEUTICALS LT

Company Type: Factory (Manufacturer)

Company Introduction:

Malladi Drugs & Pharmaceuticals Ltd. (MDPL) is a prominent Indian pharmaceutical company established in 1980. Headquartered in Chennai, India, MDPL specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs) and Pharmaceutical Intermediates.

The company is globally recognized for its expertise in producing a wide range of APIs, particularly sympathomimetic APIs and CNS stimulants. Key products include Pseudoephedrine Hydrochloride, Ephedrine Hydrochloride, Phenylephrine Hydrochloride, Norepinephrine Bitartrate, and Caffeine Anhydrous.

MDPL operates with state-of-the-art manufacturing facilities and adheres to stringent international quality standards. It holds various regulatory approvals from major global health authorities such as the USFDA, EDQM (Europe), and TGA (Australia), reflecting its strong commitment to quality and compliance. Malladi Drugs & Pharmaceuticals Ltd. serves a global clientele, exporting its products to numerous countries worldwide, making it a significant player in the global pharmaceutical industry.

Malladi Drugs and Pharmaceuticals Ltd. primarily manufactures Active Pharmaceutical Ingredients (APIs). Their product range includes Pseudoephedrine HCl, Ephedrine HCl, Phenylephrine HCl, Cetirizine HCl, Ranitidine HCl, Sertraline HCl, Venlafaxine HCl, Paroxetine HCl, Fexofenadine HCl, Levocetirizine Dihydrochloride, Tramadol HCl, Dextromethorphan HBr, Guaifenesin, Ambroxol HCl, and Bromhexine HCl.